The new trial would be run instead of adding an arm to an ongoing US trial and would evaluate a lower dosage that performed better than a full amount in AstraZeneca’s studies, according to a Bloomberg report
source https://www.hindustantimes.com/india-news/astrazeneca-may-run-additional-trial/story-Byhjrg56vr074cy34WLwFO.html
No comments:
Post a Comment